T2 Biosystems, Inc. (TTOO)

T2 Biosystems Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	78	25	10	86	183	55
Market Cap Growth	30.28%	144.54%	-87.87%	-53.30%	235.93%	-58.80%
Enterprise Value	121	59	58	110	196	88
PE Ratio	-	-0.51	-0.17	-1.74	-3.92	-0.93
PS Ratio	10.86	3.53	0.47	3.05	10.12	6.55
PB Ratio	-0.32	-0.91	-0.26	-6.64	21.03	-1.61
P/FCF Ratio	-0.26	-0.53	-0.20	-2.18	-4.17	-1.18
P/OCF Ratio	-0.26	-0.53	-0.21	-2.20	-4.25	-1.20
EV/Sales Ratio	16.81	8.16	2.59	3.93	10.84	10.58
EV/EBITDA Ratio	-1.42	-1.38	-1.08	-2.82	-5.15	-1.84
EV/EBIT Ratio	-1.35	-1.31	-1.03	-2.65	-4.76	-1.71
EV/FCF Ratio	-1.17	-1.21	-1.13	-2.80	-4.46	-1.91
Debt / Equity Ratio	-1.31	-1.77	-1.49	-4.52	6.39	-1.32
Debt / EBITDA Ratio	-1.28	-1.16	-1.10	-1.49	-1.46	-0.93
Debt / FCF Ratio	-1.05	-1.02	-1.16	-1.48	-1.27	-0.97
Quick Ratio	0.15	0.31	1.39	3.33	4.88	0.23
Current Ratio	0.28	0.45	1.91	3.80	5.47	0.31
Asset Turnover	0.21	0.19	0.53	0.40	0.28	0.20
Interest Coverage	-8.13	-8.37	-9.19	-5.48	-7.48	-7.03
Return on Equity (ROE)	150.30%	150.00%	185.40%	2845.10%	-1316.90%	306.10%
Return on Assets (ROA)	-130.50%	-135.40%	-149.40%	-70.50%	-71.50%	-144.40%
Return on Capital (ROIC)	-414.34%	-231.40%	-282.16%	-94.61%	-64.12%	-483.36%
Earnings Yield	-58.59%	-197.03%	-599.75%	-57.48%	-25.51%	-108.04%
FCF Yield	-60.27%	-190.15%	-490.40%	-45.91%	-23.99%	-84.45%
Buyback Yield / Dilution	-3637.03%	-5017.31%	-60.53%	-30.93%	-166.60%	-12.20%
Total Shareholder Return	-3637.03%	-5017.31%	-60.53%	-30.93%	-166.60%	-12.20%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).